Transferrin uptake visualization After treatment, cells were washed once with PBS and incubated with human transferrin-Alexa Fluor 647 conjugate (5 g/mL
"Should additional phase 2 and phase 3 clinical trials support repurposing one or more GLP-1 receptor agonists for AUD, these treatments could have broad clinical infiltration, with potential to bypass many traditional impediments to the uptake of AUD medications, including low public and provider awareness and stigma toward AUD treatments," the authors write
Table 1 Drug therapy in the comorbidities of diabetes and pancreatic cancer
This gradual rate is intentional: it protects muscle mass, reduces side effects, and produces durable results
The quit weight loss may also result in dehydration and hemoconcentration, where the blood becomes thicker due to an increased concentration of red blood cells and other components, slowing blood flow and increasing the likelihood of clotting
This dual-agonist approach is what sets tirzepatide apart, as it may offer enhanced effects on body weight loss and metabolic control